U.S.

Postage Paid
First-Class Mail
What is Parkinsons?

The Michael J. Fox Foundation for Parkinsons Research

Presorted

59047
Parkinsons disease is a chronic degenerative
neurological disorder, typically progressing
from mild tremors to complete physical
incapacitation.

Your donation can make a

Grand Central Station, PO Box 4777

TEMP-RETURN SERVICE REQUESTED
difference in someones life.

Our Inspiration

Attn: Veronique Enos

New York, NY 1016

Today, enormous progress is being made on
many neurological fronts, and scientists have
a much better understanding of the brain
and how disease affects it. This is an exciting
time for Parkinsons research, and advances
in the study of Parkinsons will benefit
related neurodegenerative diseases like
Alzheimers, Huntingtons, multiple
sclerosis, and ALS.
Since the day
It is for them that we will continue to
push science toward the inevitable cure as
we opened,
fast as possible.
Its the millions of Parkinsons patients
and their families worldwide who drive us
forward. Countless PD patients endeavor to
weve had one
define themselves by their achievements, not
by their individual daily struggles with PD.
There is much work still to be done, and we
must continue our aggressive fundraising in
goal in mind
closing.
support of cutting-edge research.

So one day soon, well be able to say

that Parkinsons disease truly is nobodys
disease.

The war against Parkinsons is winnable, and you can
play a part in the victory.
Michael J. Fox
Our Vision
Staff and researchers at the Michael J. Fox
Foundation for Parkinsons Research (MJFF),
have known since we began in 2000 that,
with proper funding, finding the cure for
Parkinsons disease (PD) is within reach.
Our Approach Fast Facts
Our optimism is equal to our impatience. Our unique, multidisciplinary Scientific Advisory About 40% of people diagnosed
J

Board, with members including leading with PD are under age 60.
We approach each challenge with an open Parkinsons researchers and clinicians, guides
mind and an entrepreneurial mind-set. our research efforts in three core areas: More than 1 million Americans
J

The money we raise goes quickly to the are living with PD

Detecting and preventing Parkinsons disease
J
latest cutting-edge research. As a result, the
scientific community has heralded us for There are no known ways to
J

Restoring dopamine neurons

streamlining the process and compressing the
timelineawarding most grants within six
J
prevent Parkinsons disease or to
anticipate who will get it. More
Reducing complications of treatment
J

months of announcement. than 50,000 new cases are

Today, we stand as the single largest funder
of Parkinsons research outside of the
diagnosed each year.
MJFF funds the most innovative research
The incidence of Parkinsons is
worldwide through our annual Fast Track J

program. Alongside top experts, the Scientific increasing as the Baby Boomer

Federal government.
We forged unprecedented relationships with
other private funders, as well as with the Na-
tional Institutes of Health in order to drasti-
cally reduce costs. In addition, our media and
advocacy efforts have raised awareness and
helped spur the government to increase its
own spending and get us that much closer to
a cure, that much quicker.
Advisory Board identifies specific areas where
the Foundation can dramatically advance the
science through directive programs.
Weve developed a new multi-year research
approach that brings together collaborative
teams to address big picture issues that can
have a major, immediate impact.
Quality and integrity are paramount.
population ages and as more
people are exposed to
environmental toxins.
Current treatments only mask
J
PD symptoms as the disease
continues to progress. The
efficiency of most common
therapies diminishes over time,
leaving fewer treatment options
as the disease advances.